Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
ramipril, Quantity: 1.25 mg
Strides Pharma Science Pty Ltd
Ramipril
Tablet, uncoated
Excipient Ingredients: croscarmellose sodium; sodium bicarbonate; pregelatinised maize starch; sodium stearylfumarate; lactose monohydrate
Oral
30
(S4) Prescription Only Medicine
? Treatment of hypertension. Data are currently not available to support the use of Ramipril in renovascular hypertension. ,? Post MI heart failure ,? Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularization procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmHg or diastolic blood pressure >90mmHg (or on antihypertensive treatment); total cholesterol >5.2mmol/L; HDL cholesterol <0.9mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.
Visual Identification: White to off-white coloured, flat faced bevel edged round uncoated tablet debossed with 'H' &'17' on one side and plain on other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2011-10-06
VASCALACE CONSUMER MEDICINE INFORMATION Ver 1.0 Page 1 of 6 VASCALACE Ramipril CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about VASCALACE. It does not contain all the available information about this medicine. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking VASCALACE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT VASCALACE IS USED FOR VASCALACE belongs to a group of medicines called angiotensin converting enzyme (ACE) inhibitors. VASCALACE is used to treat: • high blood pressure (hypertension) • some heart conditions such as heart failure after a heart attack • kidney problems in some patients VASCALACE is also used to reduce the risk of cardiovascular problems and complications in patients aged 55 years or more with heart or blood vessel disease, or diabetes. HYPERTENSION VASCALACE is used to lower high blood pressure (hypertension). Everyone has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day and can be influenced by how busy or worried you are. You have hypertension when your blood pressure stays higher than is needed, even when you are calm and relaxed. There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems, including stroke, heart disease and kidney failure. HEART FAILURE AFTER A HEART ATTACK VASCALACE may be used after a heart attack. A heart attack occurs when one of the major blood vessels supplying blood to your heart becomes blocked. This means that your heart muscle cannot receive the oxygen it needs and become Read the complete document
Product Information: VASCALACE Ver 1.0 Page 1 of 24 PRODUCT INFORMATION VASCALACE NAME OF THE MEDICINE The name of the medicine is ramipril. CHEMICAL NAME: (2 _S_ ,3a _S_ ,6a _S_ )-1-[(2 _S_ )-2-[[(1 _S_ )-1-(ethoxycarbonyl)-3-phenylpropyl]amino] propanoyl]octahydrocyclopenta[ _b_ ]pyrrole-2-carboxylic acid MOLECULAR FORMULA: C 23 H 32 N 2 O 5 MOLECULAR WEIGHT: 416.5 CAS REGISTRY NUMBER: [87333-19-5] DESCRIPTION Ramipril is a 2-aza-bicyclo [3.3.0]-octane-3-carboxylic acid derivative. It is a white, crystalline substance sparingly soluble in water and soluble in polar organic solvents and buffered aqueous solutions. Ramipril melts between 105°C and 112°C. Ramipril has 5 chiral centres. It has S- configuration in all 5 asymmetric carbon atoms. Ramipril pKa values are 2.98 & 4.56. VASCALACE is available as tablets containing 1.25 mg, 2.5 mg, 5 mg & 10 mg of ramipril. VASCALACE tablets contains following inactive ingredients: pregelatinised maize starch, lactose, sodium bicarbonate, croscarmellose sodium and sodium stearyl fumarate. The 2.5 mg tablet also contains iron oxide yellow CI77492. The 5mg tablet also contains iron oxide red CI77491. VASCALACE CAPS is available as capsules containing 1.25, 2.5, 5 & 10 mg ramipril. VASCALACE CAPS contain the following inactive ingredients: Colloidal anhydrous silica, pregelatinised maize starch. The capsules are made of gelatin, sodium lauryl sulphate and are coloured with titanium dioxide, iron oxide yellow (1.25 mg & 2.5 mg capsules), brilliant scarlet 4R (2.5 mg, 5 mg & 10 mg capsules) and patent blue V (5 mg & 10 mg capsules). Product Information: VASCALACE Ver 1.0 Page 2 of 24 PHARMACOLOGY MECHANISM OF ACTION Ramipril is a prodrug which, after absorption from the gastrointestinal tract, is hydrolysed in the liver to form the active moiety, ramiprilat. Ramipril and ramiprilat inhibit angiotensin-converting enzyme (ACE) which is identical to KININASE II. This converting enzyme (ACE) is a peptidyl dipeptidase that catalyses the conversion of angiotensin I to the vasoconst Read the complete document